Surgical treatment of patients with heart failure through myocardial revascularization, ventricular reconstruction, and mitral valve surgery by Buffolo, Enio
Point of View
Surgical Treatment of Patients with Heart Failure Through 
Myocardial Revascularization, Ventricular Reconstruction, and Mitral 
Valve Surgery
Enio Buffolo 
Universidade Federal de São Paulo - São Paulo, SP, Brazil
Mailing address: Enio Buffolo •  
Rua Borges Lagoa, l080/ 7º andar - 04038-030 – São Paulo, SP, Brazil 
E-mail: ebuffolo@cardiol.br 
Article received August 31, 2006; accepted September 14, 2006.
Key words
Cardiac output, low; myocardial revascularization; heart 
ventricles/surgery; mitral valve/surgery.
Heart failure, a final outcome of different cardiomyopathies 
is currently the most serious problem in the field of cardiology 
and public health. 
Despite the extraordinary progress made over the last two 
decades regarding the understanding of the deeper mechanisms 
of ventricular failure as an endocrine-metabolic syndrome, it is 
the major cause of death in the adult population.
This justifies the use of polypharmacy with five or more 
active principles with a view to neutralizing different stages 
of the adrenergic stimulation cascade. 
The clinical application of these active principles fascinates 
professionals, leading them to attach great importance to 
the heart failure syndrome, so much so that they sometimes 
accept the etiology of the disease without further questioning 
and, beyond that, fail to identify causes of heart failure that 
could be removed. 
The identification of the causal mechanism of the disease 
and its removal or neutralization translates into a significant 
impact on the progression of the disease. This is the case of 
ischemic myocardiopathies, tachymyopathies, deposit and 
metabolic diseases and others. 
With the emergence of important and recent concepts 
on ventricular dynamics under the light of the double helix 
helicoidal mechanism and the acknowledgement of the 
harmful effects of ventricular sphericity, it is necessary to 
approach heart failure from a mechanicist point of view that is 
not opposed to the endocrine-metabolic concepts, but allows 
the expectation of a better management of this syndrome. 
Among the possibilities of surgical intervention in these 
situations, we will briefly discuss the revascularization of 
ischemic myocardium, ventricular reconstruction and the 
repair of secondary mitral insufficiency.
Myocardial revascularization
Myocardial ischemic dysfunction can be reversed by 
surgical treatment, in sharp contrast with clinical management 
alone, as demonstrated by several studies; it constitutes  a 
major criterion for surgery indication1-5. 
More recently, the Ephesus and Valiant studies, with cut-
off values for ejection fraction between 0.35 and 0.40 have 
proved the advantages of surgical revascularization over 
clinical management in the medium to long term. 
It is worthy of notice that with the assessment of ischemia 
using scintigraphy, stress-echo test and more recently nuclear 
magnetic resonance imaging, the results are predictable to a 
high degree, whereas the statement of absence of ischemia, 
even if a pet scan is conducted, is subject to an error risk of 
approximately 20%.
It is therefore difficult to deny the indication of 
revascularization in patients with poor ventricular performance 
when there are approachable distal coronary beds.
There are doubts as to the benefit of revascularization 
when ventricular volumes are increased, and the results are 
not as satisfactory as revascularization in patients without an 
enlarged left ventricle6-8.
These observations constitute the basis for the proposal 
of associating some type of ventricular reconstruction with 
myocardial revascularization, and the clinical application of 
current concepts that state that ventricular contraction is due 
to a single muscle that curls over itself is very promising.
Ventricular reconstruction
The impact of the resection of dyskinetic areas of the left 
ventricle on the progression of ischemic cardiomyopathy9,10 
has long been known. More recently the SAVER11 and 
RESTORE12,13 studies pointed to the need for resection of 
fibrotic areas, even those that are akinetic, thus justifying the 
design of the recently completed STICH study. 
The concept of “helical heart” originally described by 
Torrent Guasp embodies the basis for understanding how 
ventricular reconstruction can be performed with greater 
efficiency so as to restore the heart’s elliptical form14,15. 
At present, the possibility of improving ventricular 
performance by excluding transmural fibrosis areas in 
association with myocardial revascularization is a field of 
extraordinary interest and shows a possibility of progress.
Well conducted experimental studies support the idea of 
preventing, through surgery, the expansion of infarcted areas 
which show an impairment of the function of the remaining 
myocardium16.
It is advisable, in view of this clinical and experimental 
evidence, that when indicating and planning the surgical 
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lowered ejection fraction, the presence of areas with fibrosis 
should be studied, preferably by cardiac magnetic resonance 
and the tagging of regional motility.
The results of the STICH study are expected with great 
interest: one of its arms is isolated revascularization and the 
other is revascularization with associated ventricular plasties.
Mitral valve surgery
The secondary mitral insufficiency that appears in the initial 
stages of heart failure is a factor with considerable negative 
impact on the prognosis17. 
This regurgitation is based on the  left ventricle sphericity, 
which will determine the distancing of the papillaries, the 
dilation of the ring and additional loss of contractile function 
with an increase in wall tension and energy consumption.
The proposal for repairing this regurgitation using mitral 
repair was first put forward by Chen et al18 and later publicized 
by Bolling et al19.
This technique aims at repairing an additional overload 
of the left ventricle, eliminating the regurgitant flow and 
increasing the systolic volume without having the improvement 
of the ejection fraction as a primary objective. 
We proposed a more comprehensive technique. Through 
the implant of prosthesis in A-V position, the mitral insufficiency 
is repaired, the mitral ring is remodeled and the parallelism of 
the papillary muscles is restored20. This technique has been 
modified and applied by others21,22. 
The selection of patients for this type of procedure 
requires special care. The etiology of myocardiopathy is 
not a relevant factor for its indication. It is fundamental 
to identify moderate or severe mitral insufficiency using 
transesophageal echocardiography. It is worth highlighting 
that the detection of insufficiency in these situations through 
physical examination, radiology tests and ventriculography 
often underestimates its importance. 
On the other hand, it is known that the degree of mitral 
insufficiency is not static, and may vary according to the 
patient’s degree of compensation. In cases of non severe 
mitral insufficiency with ventricular desynchrony, the 
resynchronization may replace valve surgery. 
Our recently published results for a consecutive series of 
116 patients allowed us to observe a consistent improvement 
in functional class, a significant increase of the ejection 
volume, the elimination of a regurgitant fraction and a 
decrease in LV sphericity23.
Although the hospital mortality was considerable (16.3%), 
life expectancy at the end of 5 years was in the region of 
60% including the hospital stay, which is similar to the results 
obtained with heart transplant.
In conclusion, we believe that it is valid to propose the 
elimination of secondary mitral insufficiency and the modeling 
of the ventricular cavity with the implant of a valvular prosthesis 
in patients with advanced heart failure, in order to improve the 
patient’s quality of life, delay or create conditions for a heart 
transplant and, in few cases of reversible myocardiopathies, 
as a transition path to cure.
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